Original Research
Published on 21 Jul 2011
Guggulsterone-Mediated Enhancement of Radiosensitivity in Human Tumor Cell Lines
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2011.00019
- 6,933 views
- 15 citations
134 articles related to "Tumor Cell Lines"
Articles
Original Research
Published on 07 Mar 2024
Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1341804
- 5,361 views
- 4 citations
Original Research
Published on 12 Sep 2017
Analysis of Contractility and Invasion Potential of Two Canine Mammary Tumor Cell Lines
in Veterinary Clinical, Anatomical, and Comparative Pathology
Frontiers in Veterinary Science
doi 10.3389/fvets.2017.00149
- 5,719 views
- 7 citations
Original Research
Published on 06 Apr 2018
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2018.00146
- 10,079 views
- 36 citations
Original Research
Published on 15 Nov 2023
Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
in Oncology in Veterinary Medicine
Frontiers in Veterinary Science
doi 10.3389/fvets.2023.1279535
- 3,560 views
- 5 citations
Original Research
Published on 20 Sep 2018
Differential Regulation of PIWI-LIKE 2 Expression in Primordial Germ Cell Tumor Cell Lines by Promoter Methylation
in Epigenomics and Epigenetics
Frontiers in Genetics
doi 10.3389/fgene.2018.00375
- 3,549 views
- 5 citations
Original Research
Published on 26 May 2020
Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules
in Computational Genomics
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2020.00507
- 6,514 views
- 16 citations
Original Research
Published on 08 Mar 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1102282
- 43,002 views
- 23 citations
Original Research
Published on 04 Feb 2021
Detection of Epithelial Cell Adhesion Molecule in Feline Normal and Tumor Cell Lines and Tissues With Selected Commercial Anti-human EpCAM Antibodies
in Veterinary Clinical, Anatomical, and Comparative Pathology
Frontiers in Veterinary Science
doi 10.3389/fvets.2021.622189
- 6,989 views
- 1 citation
Original Research
Published on 05 May 2025
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1585597
- 4,177 views
- 2 citations
Original Research
Published on 04 Jan 2023
Dosimetric quantities and cell survival for spatially fractionated radiation therapy
in Medical Physics and Imaging
Frontiers in Physics
doi 10.3389/fphy.2022.1064860
- 4,704 views
- 19 citations
Original Research
Published on 14 Nov 2018
Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2018.00525
- 5,020 views
- 20 citations
Original Research
Published on 29 Sep 2022
Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2022.999298
- 4,089 views
- 1 citation
Original Research
Published on 21 Jan 2021
Antiproliferative Sorbicillinoids From the Deep-Sea-Derived Penicillium allii-sativi
in Microbial Physiology and Metabolism
Frontiers in Microbiology
doi 10.3389/fmicb.2020.636948
- 4,234 views
- 17 citations
Original Research
Published on 12 Aug 2025
Mechanism of action of over-expressing NY-ESO-1 in vesicular stomatitis virus and its combination therapy with NY-ESO-1 TCR-T
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1617941
- 3,434 views
- 2 citations
Original Research
Published on 13 Jul 2022
A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.865085
- 4,489 views
- 2 citations